Home › Mieloma multiplo › California › Santa Monica
Studi clinici su Mieloma multiplo a Santa Monica, CA
8 studi su Mieloma multiplo cercano partecipanti presso sedi a Santa Monica e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
In reclutamentoFase 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · a 6 mi di distanza
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
In reclutamentoFase 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · a 6 mi di distanza
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
In reclutamentoFase 3
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi di distanza
- Clinical Research Advisors (Encino Satellite Location), Encino · a 10 mi di distanza
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
In reclutamentoFase 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
In reclutamentoFase 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · a 6 mi di distanza
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
In reclutamentoFase 3
- GSK Investigational Site, Beverly Hills · a 6 mi di distanza
Studi su Mieloma multiplo in altre città
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA42 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Edison, NJ22 studi
Altri studi a Santa Monica
- Cancro del polmone non a piccole cellule45 studi
- Cancro al seno28 studi
- Cancro colorettale23 studi
- Cancro (tutti i tipi)22 studi
- Cancro metastatico19 studi
- Cancro ai polmoni15 studi
- Cancro ovarico15 studi
- Cancro alla prostata15 studi
- Carcinoma a cellule squamose della testa e del collo13 studi
- Insufficienza cardiaca11 studi
- Cancro dell'endometrio10 studi
- Cancro dello stomaco9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.